Evidence map›Paper›PMID 34073600›Full record

ReviewInternational journal of molecular sciences2021

Nicotinamide N-Methyltransferase in Acquisition of Stem Cell Properties and Therapy Resistance in Cancer.

Renata Novak Kujundžić, Marin Prpić, Nikola Đaković, Nina Dabelić, Marko Tomljanović, Anamarija Mojzeš, Ana Fröbe, Koraljka Gall Trošelj

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. NADJournal for immunotherapy of cancer · 2024
    Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Glioblastoma and Methionine Addiction.International journal of molecular sciences · 2022
    Review
  15. Review
  16. Review
  17. Advances in Cancer Metabolism and Tumour Microenvironment.International journal of molecular sciences · 2022
    Article
  18. Review
  19. Review
  20. NicotinamideBiomolecules · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Renata Novak KujundžićLaboratory for Epigenomics, Division of Molecular Medicine, Ruđer Bošković Institute, 10000 Zagreb, Croatia.
Marin PrpićDepartment of Oncology and Nuclear Medicine, University Hospital Center Sestre Milosrdnice, 10000 Zagreb, Croatia.
Nikola ĐakovićDepartment of Clinical Oncology, School of Medicine, University of Zagreb, 10000 Zagreb, Croatia.
Nina DabelićDepartment of Oncology and Nuclear Medicine, University Hospital Center Sestre Milosrdnice, 10000 Zagreb, Croatia.
Marko TomljanovićLaboratory for Epigenomics, Division of Molecular Medicine, Ruđer Bošković Institute, 10000 Zagreb, Croatia.
Anamarija MojzešLaboratory for Epigenomics, Division of Molecular Medicine, Ruđer Bošković Institute, 10000 Zagreb, Croatia.
Ana FröbeDepartment of Oncology and Nuclear Medicine, University Hospital Center Sestre Milosrdnice, 10000 Zagreb, Croatia.ORCID 0000-0002-5834-9841
Koraljka Gall TrošeljLaboratory for Epigenomics, Division of Molecular Medicine, Ruđer Bošković Institute, 10000 Zagreb, Croatia.ORCID 0000-0001-7501-7614
Ruđer Bošković Institute · HRUniversity of Zagreb · HR

Funding

Hrvatska Zaklada za Znanost IP-2016-06-4404
6 · The paper itself

Abstract

The activity of nicotinamide N-methyltransferase (NNMT) is tightly linked to the maintenance of the nicotinamide adenine dinucleotide (NAD

Indexed as

NeoplasmsHumansMethylationNADNeoplasm ProteinsNeoplastic Stem CellsNiacinamideNicotinamide N-MethyltransferaseNADNeoplasm ProteinsNiacinamideNicotinamide N-Methyltransferasealdehyde oxidasecancerepigenetic reprogrammingnicotinamide adenine dinucleotidenicotinamide N-methyltransferasesenescencestem cell propertiestherapy resistance

Identifiers

PMID34073600
PMCPMC8197977
OpenAlexW3164746428

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.